Strategies selected
Most very early + early HCC
Lowest lifetime cost
Highest QALY
ICER
Outcome comparison across selected strategies
HCC cases detected by disease stage
Stacked bars compare very early, early, and intermediate/advanced HCC cases across all selected strategies.
Tip: Hover over each colored bar segment to view the exact number of HCC cases detected at that disease stage.
Very early HCCEarly HCCIntermediate/advanced HCC
Tests performed
Diagnostic MRI, diagnostic CT, and surveillance test counts are shown in separate panels.
No. of Diagnostic MRI Performed
No. of Diagnostic CT Performed
No. of Surveillance Test Performed
Incremental ICER table
| Strategy | Cost | QALY | Incremental cost | Incremental QALY | Incremental ICER | Incremental status |
|---|
Incremental ICERs are calculated only among strategies that remain on the efficient frontier after excluding dominated and extendedly dominated strategies.
Incremental cost-effectiveness analysis
Selected strategies are ordered by lifetime cost. Strictly dominated and extendedly dominated strategies are excluded before incremental ICERs are calculated along the efficient frontier.
Efficient frontierDominated / excluded
Selected strategy details
| Strategy | Sens. | Spec. | Cost input | Unit cost | Adherence | Lifetime cost | QALY | Total HCC | Very early | Early | Intermediate/advanced | MRI | CT | Biopsy |
|---|